
Telix Pharmaceuticals: Corporate Action—Vote in Favor of Share Issues to Acquire ITM
Telix Pharmaceuticals will hold a general meeting on Dec. 1 to vote on proposed share issues to buy ITM Isotope Technologies. The transaction, for a headline upfront consideration of USD 1.65 billion, was first announced on Sept. 21, inclusive of USD 302 million in debt.